YKL-40 Protein Correlates with the Phenotype of Asthma

Lung

Volumn 193, Issue 2, 2015, Pages 189-194

  Specjalski, Krzysztof ^a   Chełmińska, Marta ^a   Jassem, Ewa ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Asthma biomarkers; Asthma phenotypes; Chitinase like protein; YKL 40

Indexed keywords

CHITINASE; PEPTIDES AND PROTEINS; PROTEIN YKL 40; UNCLASSIFIED DRUG; ADIPOCYTOKINE; BIOLOGICAL MARKER; CHI3L1 PROTEIN, HUMAN; CHITINASE 3 LIKE PROTEIN 1; LECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBESITY; PHENOTYPE; PRICK TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPIROMETRY; BLOOD; CASE CONTROL STUDY; COMPLICATION; DISEASE COURSE; IMMEDIATE TYPE HYPERSENSITIVITY; MIDDLE AGED; ONSET AGE; PATHOPHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADIPOKINES; ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ASTHMA; BIOMARKERS; CASE-CONTROL STUDIES; CHITINASE-3-LIKE PROTEIN 1; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LECTINS; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; YOUNG ADULT;

EID: 84925536465     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-015-9693-y     Document Type: Article

References (32)

1. Global Initiative for Asthma (GINA). www.ginasthma.org. Accessed May 2014
2. Rackemann F (1947) A working classification of asthma. Am J Med 3:601–606
3. Humbert M, Durham S, Ying S et al (1996) IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and non-atopic asthma: evidence against “intrinsic” asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 154:1497–1504
4. Anderson GP (2008) Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372:1107–1119
5. Lotvall J, Akdis C, Bacharier L et al (2011) Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 127:355–360
6. Wenzel S (2012) Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 18:716–725
7. Ghidifan S, Verin E, Couderc L et al (2010) Exhaled nitric oxide fractions are well correlated with clinical control in recurrent infantile wheeze treated with inhaled corticosteroids. Pediatr Allergy Immunol 21:1015–1020
8. Berry M et al (2007) Pathological features and inhaled corticosteroids response of eosinophilic and non-eosinophilic asthma. Thorax 62:1043–1049
9. Dogherty R et al (2010) Accumulation of intraepithelial mast cells with a unique protease phenotype in Th2-high asthma. J Allergy Clin Immunol 125(1046–1053):e8
10. Specjalski K, Jassem E (2011) YKL-40 protein is a marker of asthma. J Asthma 48:767–772
11. Wang D, Zhai B, Hu F et al (2012) High YKL-40 serum concentration is correlated with prognosis of Chinese patients with breast cancer. PLoS One 7:e51127. doi:10.1371/journal.pone.0051127
12. Sakazaki Y, Hoshino T, Takei S et al (2011) Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD. PLoS One 6:e24177. doi:10.1371/journal.pone.0024177
13. Iwamoto F, Hottinger A, Karimi S et al (2011) Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas. Neuro Oncol 13:1244–1251
14. Tang H, Fang Z, Sun Y et al (2010) YKL-40 in asthmatic patients and its correlations with exacerbation, eosinophils and immunoglobulin E. Eur Respir J 35:757–760
15. Otsuka K, Matsumoto H, Niimi A et al (2012) Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease. Respiration 83:507–519
16. Gavala ML, Kelly EAB, Esnault S et al (2012) Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma. Clin Exp Allergy 43:187–197
17. Lee JH, Park KH, Park JW et al (2012) YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma. J Investig Allergol Clin Immunol 22:501–507
18. Elias J, Homer R, Hamid Q et al (2005) Chitinases and chitinase-like proteins in Th2 inflammation and asthma. J Allergy Clin Immunol 116:497–500
19. Rathcke C, Persson F, Tarnow L et al (2009) YKL-40, a marker of inflammation and endothelial dysfunction is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 32:323–328
20. Santos C, Davidson J, Covar R, Spahn J (2014) The chitinase-like protein YKL-40 is not a useful biomarker for severe persistent asthma in children. Ann Allergy Asthma Immunol 113:263–266
21. Konradsen J, James A, Nordlund B et al (2013) The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma. J Allergy Clin Immunol 132:328–335
22. Duru S, Yϋce G, Ulasli S et al (2013) The relationship between serum YKL-40 levels and severity of asthma. Iran J Allergy Asthma Immunol 12:247–253
23. Kuepper M, Bratke K, Virchow J (2008) Chitinase- like protein and asthma. N Engl J Med 358:10
24. Zhu Z, Zheng T, Homer R et al (2004) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304:1678–1682
25. Shibata Y, Foster L, Bradfield J et al (2000) Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse. J Immunol 164:1314–1321
26. Bara I, Ozier A, Girodet P et al (2012) Role of YKl-40 in bronchial smooth muscle remodeling in asthma. Am J Respir Crit Care Med 185:715–722
27. Chupp G, Lee C, Jarjour N et al (2007) A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 357:2016–2027
28. Ober C, Tan Z, Sun Y et al (2008) Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma and lung function. N Engl J Med 358:1682–1691
29. Son M, Lee J, Kim K et al (2009) Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. Am J Respir Crit Care Med 179:449–456
30. Guerra S, Halonen M, Sherrill D et al (2013) The relation of circulating YKL-40 to levels and decline of lung function in adult life. Respir Med 107:1923–1930
31. Hotamisligil G, Shargill N, Spiegelman B (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87–91
32. Loffreda S (1998) Leptin regulates proinflammatory immune responses. FASEB J 12:57–65